Edwards Lifesciences
1,043 hedge funds and large institutions have $35.1B invested in Edwards Lifesciences in 2020 Q2 according to their latest regulatory filings, with 126 funds opening new positions, 367 increasing their positions, 372 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1% less repeat investments, than reductions
Existing positions increased: 367 | Existing positions reduced: 372
33% less funds holding in top 10
Funds holding in top 10: 21 → 14 (-7)
164.76% less ownership
Funds ownership: 246.51% → 81.75% (-165%)
Holders
1,043
Holding in Top 10
14
Calls
$170M
Puts
$153M
Top Buyers
| 1 | +$239M | |
| 2 | +$122M | |
| 3 | +$108M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$99.2M |
| 5 |
KBC Group
Brussels,
Belgium
|
+$69.6M |
Top Sellers
| 1 | -$445M | |
| 2 | -$142M | |
| 3 | -$117M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$105M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
-$101M |